Daiichi Sankyo Starts Patient dosing in DESTINY-Lung04 Phase 3 trial of Enhertu
Summary : Daiichi Sankyo Company, Limited announced that the first patient was dosed in the global DESTINY-Lung04 phase 3 trial evaluating the…
Summary : Daiichi Sankyo Company, Limited announced that the first patient was dosed in the global DESTINY-Lung04 phase 3 trial evaluating the…